| Dissecting the genomic complexity underlying medulloblastoma DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ... Nature 488 (7409), 100-105, 2012 | 980 | 2012 |
| Treatment of early childhood medulloblastoma by postoperative chemotherapy alone S Rutkowski, U Bode, F Deinlein, H Ottensmeier, M Warmuth-Metz, ... New England Journal of Medicine 352 (10), 978-986, 2005 | 885 | 2005 |
| Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90 A Reiter, M Schrappe, M Tiemann, WD Ludwig, E Yakisan, ... Blood, The Journal of the American Society of Hematology 94 (10), 3294-3306, 1999 | 598 | 1999 |
| The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95 W Woessmann, K Seidemann, G Mann, M Zimmermann, B Burkhardt, ... Blood 105 (3), 948-958, 2005 | 468 | 2005 |
| Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the … N Fuchs, SS Bielack, D Epler, P Bieling, G Delling, D Körholz, N Graf, ... Annals of oncology 9 (8), 893-899, 1998 | 425 | 1998 |
| Advances in Wilms tumor treatment and biology: progress through international collaboration JS Dome, N Graf, JI Geller, CV Fernandez, EA Mullen, F Spreafico, ... Journal of Clinical Oncology 33 (27), 2999-3007, 2015 | 417 | 2015 |
| Toward the blood-borne miRNome of human diseases A Keller, P Leidinger, A Bauer, A ElSharawy, J Haas, C Backes, ... Nature methods 8 (10), 841-843, 2011 | 400 | 2011 |
| Making sense of big data in health research: towards an EU action plan C Auffray, R Balling, I Barroso, L Bencze, M Benson, J Bergeron, ... Genome medicine 8, 1-13, 2016 | 357 | 2016 |
| Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol MM Van Den Heuvel-eibrink, JA Hol, K Pritchard-Jones, H Van Tinteren, ... Nature Reviews Urology 14 (12), 743-752, 2017 | 341 | 2017 |
| Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors J Wegert, N Ishaque, R Vardapour, C Geörg, Z Gu, M Bieg, B Ziegler, ... Cancer cell 27 (2), 298-311, 2015 | 336 | 2015 |
| Childhood cancer predisposition syndromes—a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology T Ripperger, SS Bielack, A Borkhardt, IB Brecht, B Burkhardt, ... American journal of medical genetics Part A 173 (4), 1017-1037, 2017 | 325 | 2017 |
| Malignant renal tumours incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project G Pastore, A Znaor, F Spreafico, N Graf, K Pritchard-Jones, ... European journal of cancer 42 (13), 2103-2114, 2006 | 317 | 2006 |
| Obesity after childhood craniopharyngioma-German multicenter study on pre-operative risk factors and quality of life HL Müller, K Bueb, U Bartels, CH Roth, K Harz, N Graf, R Korinthenberg, ... Klinische Pädiatrie 213 (04), 244-249, 2001 | 313 | 2001 |
| THE ROLE OF PREOPERATIVE CHEMOTHERAPY IN THE MANAGEMENT OF WILMS'TUMOR: The SIOP Studies N Graf, MF Tournade, J de Kraker Urologic Clinics of North America 27 (3), 443-454, 2000 | 297 | 2000 |
| Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death CA Koks, AD Garg, M Ehrhardt, M Riva, L Vandenberk, L Boon, ... International journal of cancer 136 (5), E313-E325, 2015 | 254 | 2015 |
| The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol GM Vujanić, M Gessler, AHAG Ooms, P Collini, A Coulomb-l’Hermine, ... Nature Reviews Urology 15 (11), 693-701, 2018 | 250 | 2018 |
| Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial J De Kraker, N Graf, H Van Tinteren, F Pein, B Sandstedt, J Godzinski, ... The Lancet 364 (9441), 1229-1235, 2004 | 249 | 2004 |
| Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 U Creutzig, M Zimmermann, JP Bourquin, MN Dworzak, G Fleischhack, ... Blood, The Journal of the American Society of Hematology 122 (1), 37-43, 2013 | 240 | 2013 |
| Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML … U Creutzig, M Zimmermann, T Lehrnbecher, N Graf, J Hermann, ... Journal of clinical oncology 24 (27), 4499-4506, 2006 | 226 | 2006 |
| Wilms tumour: prognostic factors, staging, therapy and late effects SC Kaste, JS Dome, PS Babyn, NM Graf, P Grundy, J Godzinski, GA Levitt, ... Pediatric radiology 38, 2-17, 2008 | 219 | 2008 |
Harm van TinterenHoofd Trial en Datacentrum, Prinses Maxima Centrum確認したメール アドレス: prinsesmaximacentrum.nl